Notoginsenoside Ft1
Notoginsenoside Ft1 Basic information
- Product Name:
- Notoginsenoside Ft1
- Synonyms:
-
- Notoginsenoside Ft1
- (3beta,12beta,20R)-12,20-Dihydroxydammar-24-en-3-yl O-beta-D-xylopyranosyl-(1- 2)-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranoside
- product/153944
- β-D-Glucopyranoside, (3β,12β,20R)-12,20-dihydroxydammar-24-en-3-yl O-β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→2)-
- (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
- CAS:
- 155683-00-4
- MF:
- C47H80O17
- MW:
- 917.13
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Mol File:
- 155683-00-4.mol
Notoginsenoside Ft1 Chemical Properties
- Boiling point:
- 997.8±65.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- solubility
- DMF: 20 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 15 mg/ml; Ethanol: 5 mg/ml
- form
- A crystalline solid
- pka
- 12.84±0.70(Predicted)
- color
- White to off-white
Notoginsenoside Ft1 Usage And Synthesis
Description
Notoginsenoside Ft1 is a saponin originally isolated from P. notoginseng with diverse biological activities. It induces proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs) via nuclear translocation of hypoxia-inducible factor-1α (HIF-1α) and activation of the PI3K/AKT and Raf/MEK/ERK signaling pathways in a manner dependent on mammalian target of rapamycin (mTOR). Notoginsenoside Ft1 (45 μM) induces cell cycle arrest at the S and G2/M phases and promotes apoptosis of SH-SY5Y cells. It increases cGMP levels and induces relaxation of isolated precontracted rat mesenteric arteries, effects that are reversed by the nitric oxide synthase inhibitor L-NAME and ODQ , an inhibitor of soluble guanylyl cyclase. In vivo, notoginsenoside Ft1 (0.25, 2.5, and 25 mg/kg) promotes angiogenesis and decreases wound diameter in a mouse model of punched-hole ear injury. Notoginsenoside Ft1 (1.25 mg/kg) decreases tail bleeding time and increases thrombus weight in a rat tail bleeding assay. Topical administration of notoginsenoside Ft1 increases mRNA expression of the collagen expression, fibroblast proliferation, and scar formation genes COL1A1, COL3A1, TGF-β1, TGF-β3, and fibronectin, promotes neovascularization, reduces monocyte infiltration, and shortens wound closure time in a db/db mouse model of diabetic foot ulcers.
Notoginsenoside Ft1Supplier
- Tel
- 400-1166-196 18981987031
- cdhxsj@163.com
- Tel
- 0871-65217109 13211707573;
- y.liu@mail.biobiopha.com
- Tel
- 021-61312847 13636370518
- shyysw007@163.com
- Tel
- +86-028-82633397 18982077548
- cwb1@biopurify.cn
- Tel
- 400-186-5138 13341702378
- winherb@126.com
Notoginsenoside Ft1(155683-00-4)Related Product Information
- Notoginsenoside R2
- 20(R)-Notoginsenoside R2
- Notoginseng triterpenes
- Panax notoginsenosides
- Notoginsenoside R1
- Icariside I
- PICEATANNOL
- Gypenoside XLIX
- Saikosaponin G
- Palmatine
- epipinoresinol-4'-O-β-D-glucoside
- GYPENOSIDE-XVII
- Notoginsenoside Fa
- KAEMPFERITRIN
- Nobiletin
- ISOLIQUIRITIN
- Costunolide
- Forsythoside B